FIU researcher Alexander Agoulnik has discovered a new method that may reverse osteoporosis. Agoulnik found that by targeting a specific protein called SARM1, they could stimulate bone growth and reverse osteoporosis in mice, leading to the possibility of developing it for humans.
Agoulnik and their team discovered a new drug compound that can reverse osteoporosis in mice by increasing bone density. The researchers designed and synthesized the drug, named SR9009, and tested it on mice with induced osteoporosis. The compound increased bone formation and density and could potentially be used to treat osteoporosis in humans. It may be the first step toward cheaper, easy-to-take treatments for osteoporosis and other diseases associated with bone loss.
View Related Expert Profiles: Go to Source
